Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. (OPXA) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 108 transactions totaling $1.6M, demonstrating a bearish sentiment with -$726.2K in net insider flow. The most recent transaction on Nov 18, 2016 involved a sale of 7,105 shares valued at $3.9K.
OPXA Insider Activity Summary
Who Is Buying OPXA Stock?
No significant insider buying has been recorded for OPXA in the recent period.
Who Is Selling OPXA Stock?
No significant insider selling has been recorded for OPXA in the recent period.
Is Opexa Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OPXA is bearish with an Insider Alignment Score of 27/100 and a net flow of -$726.2K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
OPXA Frequently Asked Questions
Understanding OPXA Insider Activity
Insider trading at Opexa Therapeutics, Inc. (OPXA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading OPXA stock, having executed 108 transactions in the past 90 days. The most active insider is Austin W. &. Greenhouse David M. Marxe (Executive), who has made 17 transactions totaling $916.6K.
Related Tools
Track Opexa Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OPXA file new Form 4 transactions